6 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
#Profiles #SideEffects ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology # ... Management
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Diabetes Medication ... images/2507 #Management ... #DM2 #PatientInfo ... #Selection #SideEffects ... Reduction #Costs #Pharmacology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... #Pharmacology # ... Medications #DM2 ... #Diabetes #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... very tolerable medication ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Neurological Side Effects of Antipsychotic Drugs
Acute dystonia - Spasm of muscles of tongue, face, neck, back
Neurological Side Effects ... reduction; change medication ... discontinuation VMAT2 inhibitors ... #SideEffects #pharmacology ... #management
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... system (RAAS) inhibitor ... hypertension, diabetes ... monitoring to detect ... cardiology #oncology #pharmacology